4.1 MMRV randomised clinical trial ‐ any severity |
3 |
|
Rate Ratio (IV, Random, 95% CI) |
Subtotals only |
4.1.1 2 doses ‐ follow up at 5 years |
1 |
|
Rate Ratio (IV, Random, 95% CI) |
0.05 [0.03, 0.08] |
4.1.2 2 doses ‐ follow up between 5 to 10 years |
1 |
|
Rate Ratio (IV, Random, 95% CI) |
0.05 [0.04, 0.06] |
4.1.3 2 doses ‐ follow up at 10 years |
1 |
|
Rate Ratio (IV, Random, 95% CI) |
0.05 [0.04, 0.06] |
4.2 MMRV randomised clinical trial ‐ moderate/severe cases |
3 |
|
Rate Ratio (IV, Random, 95% CI) |
Subtotals only |
4.2.1 2 doses ‐ Follow up at 5 years |
1 |
|
Rate Ratio (IV, Random, 95% CI) |
0.00 [0.00, 0.02] |
4.2.2 2 doses ‐ Follow up between 5 to 10 years |
1 |
|
Rate Ratio (IV, Random, 95% CI) |
0.01 [0.00, 0.02] |
4.2.3 2 doses ‐ Follow up at 10 years |
1 |
|
Rate Ratio (IV, Random, 95% CI) |
0.01 [0.00, 0.02] |
4.3 MMR+V randomised clinical trial ‐ any severity |
3 |
|
Rate Ratio (IV, Random, 95% CI) |
0.33 [0.30, 0.36] |
4.3.1 2 doses ‐ follow up at 5 years |
1 |
|
Rate Ratio (IV, Random, 95% CI) |
0.35 [0.28, 0.43] |
4.3.2 2 doses ‐ follow up between 5 to 10 years |
1 |
|
Rate Ratio (IV, Random, 95% CI) |
0.33 [0.29, 0.38] |
4.3.3 2 doses ‐ follow up at 10 years |
1 |
|
Rate Ratio (IV, Random, 95% CI) |
0.33 [0.29, 0.38] |
4.4 MMR+V randomised clinical trial ‐ moderate/severe cases |
3 |
|
Rate Ratio (IV, Fixed, 95% CI) |
0.10 [0.08, 0.12] |
4.4.1 2 doses ‐ Follow up at 5 years |
1 |
|
Rate Ratio (IV, Fixed, 95% CI) |
0.09 [0.06, 0.14] |
4.4.2 2 doses ‐ Follow up between 5 to 10 years |
1 |
|
Rate Ratio (IV, Fixed, 95% CI) |
0.10 [0.07, 0.13] |
4.4.3 2 doses ‐ Follow up at 10 years |
1 |
|
Rate Ratio (IV, Fixed, 95% CI) |
0.10 [0.08, 0.14] |
4.5 MMR+V randomised clinical trial ‐ severe cases |
1 |
|
Rate Ratio (IV, Fixed, 95% CI) |
Subtotals only |
4.5.1 2 doses ‐ follow up between 5 to 10 years |
1 |
|
Rate Ratio (IV, Fixed, 95% CI) |
0.05 [0.01, 0.47] |
4.6 MMRV cohort study |
4 |
|
Risk Ratio (IV, Random, 95% CI) |
Subtotals only |
4.6.1 One dose ‐ any severity |
4 |
|
Risk Ratio (IV, Random, 95% CI) |
0.25 [0.11, 0.59] |
4.6.2 Two doses ‐ any severity |
2 |
|
Risk Ratio (IV, Random, 95% CI) |
0.13 [0.13, 0.14] |
4.7 MMRV case‐control |
1 |
|
Odds Ratio (IV, Random, 95% CI) |
Subtotals only |
4.7.1 Any dose ‐ any severity |
1 |
|
Odds Ratio (IV, Random, 95% CI) |
0.14 [0.07, 0.28] |
4.7.2 Any dose ‐ moderate/severe cases |
1 |
|
Odds Ratio (IV, Random, 95% CI) |
0.07 [0.03, 0.17] |
4.8 MMR+V case control |
3 |
|
Odds Ratio (IV, Random, 95% CI) |
Subtotals only |
4.8.1 1 dose ‐ any severity |
2 |
|
Odds Ratio (IV, Random, 95% CI) |
0.14 [0.08, 0.22] |
4.8.2 2 doses ‐ any severity |
2 |
|
Odds Ratio (IV, Random, 95% CI) |
0.05 [0.01, 0.14] |
4.8.3 Any dose ‐ any severity |
2 |
|
Odds Ratio (IV, Random, 95% CI) |
0.12 [0.08, 0.18] |
4.9 MMRV case only ecological method ‐ hospitalisation |
3 |
|
Rate Ratio (IV, Random, 95% CI) |
0.43 [0.34, 0.55] |
4.9.1 Age < 1 year ‐ any dose |
2 |
|
Rate Ratio (IV, Random, 95% CI) |
0.52 [0.37, 0.74] |
4.9.2 Age 1 to 4 years ‐ any dose |
2 |
|
Rate Ratio (IV, Random, 95% CI) |
0.29 [0.10, 0.85] |
4.9.3 Age 5 to 14 years ‐ any dose |
2 |
|
Rate Ratio (IV, Random, 95% CI) |
0.37 [0.19, 0.72] |
4.9.4 Age 0 to 14 years ‐ any doses |
1 |
|
Rate Ratio (IV, Random, 95% CI) |
0.53 [0.44, 0.64] |
4.10 MMRV case only ecological method ‐ incidence |
2 |
|
Rate Ratio (IV, Random, 95% CI) |
0.24 [0.14, 0.43] |
4.10.1 Age < 1 year |
1 |
|
Rate Ratio (IV, Random, 95% CI) |
0.17 [0.12, 0.24] |
4.10.2 Age 1 to 4 years ‐ any dose |
1 |
|
Rate Ratio (IV, Random, 95% CI) |
0.08 [0.07, 0.09] |
4.10.3 Age 5 to 14 years ‐ any dose |
1 |
|
Rate Ratio (IV, Random, 95% CI) |
0.14 [0.12, 0.16] |
4.10.4 Age 0 to 14 years ‐ any doses |
1 |
|
Rate Ratio (IV, Random, 95% CI) |
0.65 [0.53, 0.80] |